David O’Reilly

David O’Reilly is chairman emeritus of the Global Tobacco & Nicotine Forum (GTNF) advisory board as well as and group scientific director and R&D director of British American Tobacco (BAT). He graduated from Imperial College London in 1991 with a doctorate in molecular virology. He continued to pursue this area of research when he joined Advanced Technologies Cambridge, a BAT subsidiary, where he studied the potential of genetic modification to introduce novel processing and agronomic traits into tobacco and other crops.

O’Reilly has been a driving force behind BAT’s multidisciplinary global R&D effort in consumer-led, science-based innovation in both combustible and next-generation tobacco and nicotine products. He has also led the company’s programs in corporate social responsibility and scientific and public health policy and engagement. O’Reilly served as the first chairman of the GTNF advisory board until 2016.